Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Seminars in Immunology
|
April 15, 2008
Lymphoid tissue inducer cells in adaptive CD4 T cell dependent responses
Peter Lane, Mi-Yeon Kim, David Withers, et al.
Blood
|
May 29, 2007
Lymphotoxin a-dependent and -independent signals regulate stromal organizer cell homeostasis during lymph node organogenesis
Andrea White, Damian Carragher, Sonia Parnell, et al.
American Journal of Hematology
|
November 21, 2008
Sickle cell disease summit: from clinical and research disparity to action
Kathryn Hassell, Betty Pace, Winfred Wang, et al.
Pediatric Blood & Cancer
|
July 22, 2009
Urine concentrating ability in infants with sickle cell disease: baseline data from the phase III trial of hydroxyurea (BABY HUG)
Scott T Miller, Winfred C Wang, Rathi Iyer, et al.
Global Change Biology
|
November 16, 2018
Weather effects on birds of different size are mediated by long-term climate and vegetation type in endangered temperate woodlands
David B Lindenmayer, Peter Lane, Mason Crane, et al.
European Journal of Immunology
|
April 7, 2011
CD117⁺ CD3⁻ CD56⁻ OX40Lhigh cells express IL-22 and display an LTi phenotype in human secondary lymphoid tissues
Soochan Kim, Sinsuk Han, David R Withers, et al.
Pharmaceutical Statistics
|
October 22, 2009
Missing data: discussion points from the PSI missing data expert group
Tomasz Burzykowski, James Carpenter, Corneel Coens, et al.
American Journal of Hematology
|
November 29, 2011
Transfusional iron overload in children with sickle cell anemia on chronic transfusion therapy for secondary stroke prevention
Janet L Kwiatkowski, Alan R Cohen, Julian Garro, et al.
Acta Haematologica
|
April 15, 2008
Patient-reported outcomes of deferasirox (Exjade, ICL670) versus deferoxamine in sickle cell disease patients with transfusional hemosiderosis. Substudy of a randomized open-label phase II trial
Elliott Vichinsky, Zahra Pakbaz, Onyinye Onyekwere, et al.
British Journal of Haematology
|
May 20, 2011
Long-term safety and efficacy of deferasirox (Exjade) for up to 5 years in transfusional iron-overloaded patients with sickle cell disease
Elliott Vichinsky, Françoise Bernaudin, Gian Luca Forni, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Seminars in Immunology
|
April 15, 2008
Lymphoid tissue inducer cells in adaptive CD4 T cell dependent responses
Peter Lane, Mi-Yeon Kim, David Withers, et al.
Blood
|
May 29, 2007
Lymphotoxin a-dependent and -independent signals regulate stromal organizer cell homeostasis during lymph node organogenesis
Andrea White, Damian Carragher, Sonia Parnell, et al.
American Journal of Hematology
|
November 21, 2008
Sickle cell disease summit: from clinical and research disparity to action
Kathryn Hassell, Betty Pace, Winfred Wang, et al.
Pediatric Blood & Cancer
|
July 22, 2009
Urine concentrating ability in infants with sickle cell disease: baseline data from the phase III trial of hydroxyurea (BABY HUG)
Scott T Miller, Winfred C Wang, Rathi Iyer, et al.
Global Change Biology
|
November 16, 2018
Weather effects on birds of different size are mediated by long-term climate and vegetation type in endangered temperate woodlands
David B Lindenmayer, Peter Lane, Mason Crane, et al.
European Journal of Immunology
|
April 7, 2011
CD117⁺ CD3⁻ CD56⁻ OX40Lhigh cells express IL-22 and display an LTi phenotype in human secondary lymphoid tissues
Soochan Kim, Sinsuk Han, David R Withers, et al.
Pharmaceutical Statistics
|
October 22, 2009
Missing data: discussion points from the PSI missing data expert group
Tomasz Burzykowski, James Carpenter, Corneel Coens, et al.
American Journal of Hematology
|
November 29, 2011
Transfusional iron overload in children with sickle cell anemia on chronic transfusion therapy for secondary stroke prevention
Janet L Kwiatkowski, Alan R Cohen, Julian Garro, et al.
Acta Haematologica
|
April 15, 2008
Patient-reported outcomes of deferasirox (Exjade, ICL670) versus deferoxamine in sickle cell disease patients with transfusional hemosiderosis. Substudy of a randomized open-label phase II trial
Elliott Vichinsky, Zahra Pakbaz, Onyinye Onyekwere, et al.
British Journal of Haematology
|
May 20, 2011
Long-term safety and efficacy of deferasirox (Exjade) for up to 5 years in transfusional iron-overloaded patients with sickle cell disease
Elliott Vichinsky, Françoise Bernaudin, Gian Luca Forni, et al.
Page
of 3